Abstract
Background and aims
The Union Internationale Contre le Cancer and American Joint Committee on Cancer classification propose that pN0-classified colorectal lymphadenectomy specimens will ordinarily include 12 or more tumor-negative lymph nodes. We performed a clinical trial to investigate whether a short-term preoperative radiotherapy (5×5 Gy) leads to a reduction of the number of lymph nodes in rectal cancer specimens after total and partial mesorectal excision (TME and PME, respectively).
Materials and methods
Within a 5-year period, 28 (15%) of 148 rectal cancer patients underwent hypofractionated preoperative radiotherapy in this monocenter study, whereas 120 patients (85%) underwent TME/PME surgery alone. The main criterion was the number of lymph nodes in TME/PME specimens. We used a stratified one-sided Wilcoxon–Mann–Whitney test to test for a significant difference in the number of lymph nodes, stratifying for tumor location and postoperative tumor stage. Patients who were suspected of having any alterations in the number of pelvic lymph nodes were excluded from the study.
Results
Fewer lymph nodes were detected in the TME/PME specimens of patients who received hypofractionated preoperative radiotherapy compared to patients who underwent TME/PME surgery alone (12 detectable lymph nodes vs 15; p=0.0005). Tumor location (p=0.095) and tumor stage (p=0.093) did not significantly influence the number of lymph nodes in this study.
Conclusions
We conclude that a 5×5 Gy short-term preoperative radiotherapy leads to a reduction in the number of lymph nodes in TME/PME specimens. Because neoadjuvant therapy in rectal cancer for T2 and T3 tumors has advanced a new therapeutic standard procedure, in the future, less lymph nodes will be detected in TME/PME specimens. This might influence the required number of lymph nodes in current staging systems for rectal cancer in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564–72
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987
Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711
Heald RJ (1995) Rectal cancer: the surgical options. Eur J Cancer 31A:1189–1192
Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T et al (1999) Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch Colorectal Cancer Group. Eur J Surg 165:410–420
Stockholm Colorectal Cancer Study Group (1996) Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 3:423–430
Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B (1997) Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 43:133–137
Sobin LH, Greene FL (2001) TNM classification: clarification of number of regional lymph nodes for pNo. Cancer 92:452
Sobin LH (2003) TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol 21:19–22
Marijnen CA, Nagtegaal ID, Klein KE, Hermans J, van de Velde CJ, Leer JW et al (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Slomkowski M, Jeleniewska A, Apel D, Sablinska K, Maj S (1990) Treatment of low-malignancy lymphomas by spleen irradiation. Acta Haematol Pol 21:85–91
Terr AI, Moss RB, Strober S (1987) Effect of total lymphoid irradiation on IgE antibody responses in rheumatoid arthritis and systemic lupus erythematosus. J Allergy Clin Immunol 80:798–802
Hande MP, Boei JJ, Natarajan AT (1996) Induction and persistence of cytogenetic damage in mouse splenocytes following whole-body X-irradiation analysed by fluorescence in situ hybridization. II. Micronuclei. Int J Radiat Biol 70:375–383
Liu SZ, Zhang YC, Mu Y, Su X, Liu JX (1996) Thymocyte apoptosis in response to low-dose radiation. Mutat Res 358:185–191
Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB (1999) Modification of immune response by low dose ionizing radiation: role of apoptosis. Immunol Lett 68:237–245
Heier HE (1978) The influence of therapeutic irradiation of blood and peripheral lymph lymphocytes. Lymphology 11:238–242
Bass H, Adkins B, Strober S (1991) Thymic irradiation inhibits the rapid recovery of TH1 but not TH2-like functions of CD4+ T cells after total lymphoid irradiation. Cell Immunol 137:316–328
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maschuw, K., Kress, R., Ramaswamy, A. et al. Short-term preoperative radiotherapy in rectal cancer patients leads to a reduction of the detectable number of lymph nodes in resection specimens. Langenbecks Arch Surg 391, 364–368 (2006). https://doi.org/10.1007/s00423-006-0056-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-006-0056-2